Company Overview and News

0
China crude imports rise, but capped by weak 'teapot' demand

2018-08-08 reuters
BEIJING (Reuters) - China’s crude oil imports recovered slightly in July after falling for the previous two months, but were still among the lowest this year due to a drop-off in demand from the country’s smaller independent, or “teapot”, refineries.
0386

1
Ex-assistant chairman of China's banking regulator sentenced to 16 years in prison: state media

2018-07-26 reuters - 1
HONG KONG (Reuters) - The former assistant chairman of China’s banking regulatory commission has been sentenced to 16 years in prison for accepting bribes, state media said on Thursday, as the Chinese government clamps down on corruption.
CHIB 0386 CKGOY

1
Ex-assistant chairman of China's banking regulator sentenced to 16 years in prison: state media

2018-07-26 channelnewsasia - 1
HONG KONG: The former assistant chairman of China's banking regulatory commission has been sentenced to 16 years in prison for accepting bribes, state media said on Thursday, as the Chinese government clamps down on corruption.
CHIB 0386 CKGOY

0
MOVES-JPMorgan hires five research analysts to boost China coverage - memo

2018-07-24 reuters
HONG KONG, July 24 (Reuters) - JPMorgan Chase & Co has hired five industrial sector research analysts from rivals including Morgan Stanley, Nomura and UBS to bolster coverage of Chinese listed companies, according to an internal memo seen by Reuters.
MS 0386

4
Hong Kong, China stocks fall anew ahead of US announcement of tariffs on Chinese goods

2018-06-15 scmp
Hang Seng Index posts its biggest weekly drop in two months while the Shanghai index falls to 20-month closing low
ANPDF 55BC 2331 CBQS 0386 CICHY 1368 ANPDY XTPEF 0700 XTEPY CICHF CCB 0939

16
London aluminium up for 6th day after LME suspends Rusal metal

2018-04-11 thehindubusinessline
The most-traded June aluminium contract on the Shanghai Futures Exchange edged up 0.1 per cent to 14,360 yuan ($2,286) a tonne.
RTPPF RIO RIO RIO RUALF RTNTF 0386

0
Sinopec USA turns copper buyer to supply China operations - sources

2018-04-11 channelnewsasia
SANTIAGO: The U.S. unit of China's oil major Sinopec Corp is procuring copper to send to its equipment suppliers in China, two sources familiar with the matter told Reuters, a rare move by a Chinese oil company.
SCCO 0386

0
Exclusive: Sinopec USA turns copper buyer to supply China operations - sources

2018-04-10 channelnewsasia
The U.S. unit of China's oil major Sinopec Corp is procuring copper to send to its equipment suppliers in China, two sources familiar with the matter told Reuters, a rare move by a Chinese oil company.
SCCO 0386

0
Exclusive: Sinopec USA turns copper buyer to supply China operations - sources

2018-04-10 reuters
SANTIAGO (Reuters) - The U.S. unit of China’s oil major Sinopec Corp (0386.HK) is procuring copper to send to its equipment suppliers in China, two sources familiar with the matter told Reuters, a rare move by a Chinese oil company.
SCCO 0386

Related Articles

REPH: Recro Pharma Analysis and Research Report

5h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

5h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

6h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...